If Congress starts reviewing licensing deals, diligence gets a documentation problem
General Idaho
Archived
•
October 5, 2026
•
Historically, national security reviews were not a topic of conversation in biotech licensing deals. Things are changing. The bipartisan Biotech Investment National Security Act of 2026 would amend the COINS Act by adding biotechnology as a covered sector, expand reviewable transactions to include licensing deals, and give the U.S. Treasury a year to write rules
Source: Local News 8 (KIFI) | https://localnews8.com/feed/ - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



